Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2647949-48-0
2. Ontunisertib [inn]
3. Sf6hgc94lk
4. Agmb-129
5. Orb2944887
6. Schembl28822081
7. Gtpl13846
8. Org-129
9. Bdbm739530
10. Us12297186, Example 24
11. Ex-a16343
12. Example 26 [wo2021105317a1]
13. Hy-168990
14. 1h-pyrazole-1-acetamide, N-[(2,6-difluorophenyl)methyl]-3-(6-methyl-2-pyridinyl)-4-(4-quinolinyl)-
15. N-(2,6-difluorobenzyl)-2-(3-(6-methylpyridin-2-yl)-4-(quinolin-4-yl)-1h-pyrazol-1-yl)acetamide
16. N-[(2,6-difluorophenyl)methyl]-2-[3-(6-methylpyridin-2-yl)-4-quinolin-4-ylpyrazol-1-yl]acetamide
17. N-[(2,6-difluorophenyl)methyl]-3-(6-methyl-2-pyridinyl)-4-(4-quinolinyl)-1h-pyrazole-1-acetamide
| Molecular Weight | 469.5 g/mol |
|---|---|
| Molecular Formula | C27H21F2N5O |
| XLogP3 | 4.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 72.7 |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 703 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
71
PharmaCompass offers a list of Ontunisertib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ontunisertib manufacturer or Ontunisertib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ontunisertib manufacturer or Ontunisertib supplier.
A Ontunisertib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ontunisertib, including repackagers and relabelers. The FDA regulates Ontunisertib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ontunisertib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ontunisertib supplier is an individual or a company that provides Ontunisertib active pharmaceutical ingredient (API) or Ontunisertib finished formulations upon request. The Ontunisertib suppliers may include Ontunisertib API manufacturers, exporters, distributors and traders.
Ontunisertib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ontunisertib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ontunisertib GMP manufacturer or Ontunisertib GMP API supplier for your needs.
A Ontunisertib CoA (Certificate of Analysis) is a formal document that attests to Ontunisertib's compliance with Ontunisertib specifications and serves as a tool for batch-level quality control.
Ontunisertib CoA mostly includes findings from lab analyses of a specific batch. For each Ontunisertib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ontunisertib may be tested according to a variety of international standards, such as European Pharmacopoeia (Ontunisertib EP), Ontunisertib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ontunisertib USP).
